Shawn Ritchie | Chief Executive Officer
Med-Life Discoveries
Currently the CEO and CSO of Med-Life Discoveries with over 20 years of experience in the biotech sector. My primary objective at the meeting is to seek investment opportunities and/or potential co-development or licensing partners for our rare disease program.
Appearances:
Day 1 - Wednesday 28 October @ 16:00
Metabolic plasmalogen replacement therapy for a rare peroxisomal disorder – Title tbc
last published: 14/Jul/25 09:35 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events